Kidneys, the set of bean shaped organs in the lower abdomen, are the most essential part of our body. They do the function of filtering the impure blood and producing urine and later helping us excrete it out. Almost all kidney cancers first appear in the lining of tiny tubes (tubules) in the kidney. This type of kidney cancer is called renal cell carcinoma. Kidneys are often neglected when giving priority among organs, due to the lack of knowledge about their need and functionality of the body.
Kidney Cancer, also called Renal Cancer is the uncontrolled growth of Kidney cells, forming tumors. The most dangerous thing about kidney cancer is the symptoms. There are no early symptoms which makes it difficult to detect. Blood in urine, pain in abdomen, small lumps in the abdomen, fever that lasts for weeks without a reason, loss of appetite, extreme loss of weight and swelling near ankles are few of the symptoms that show up a few years of the cancer starts. These symptoms alone cannot be used as evidence to confirm the presence of kidney cancer.
Surprisingly, scientists have not been able to clearly define the proper causes of kidney cancer. The most frequent causes found in people suffering with Renal Cancer is smoking and drinking habits. People above the age of 40 are more likely to get renal cancer. Having certain genetic conditions, such as von Hippel-Lindau (VHL) disease or inherited papillary renal cell carcinoma. Excessive usage of particular drugs on regular basis for a long time and being exposed to certain kinds of chemicals can lead to kidney cancer. People who are obsess or have a family history of kidney cancer, all lead to kidney cancer.
Kidney cancer can be detected using the right tools and the proper time. Blood test and Urine test are still the simplest methods of understanding the diagnosis of kidney cancer. Intravenous pyelogram (IVP) involves X-raying your kidneys after the doctor injects a dye that travels to your urinary tract, highlighting any tumors. A ‘CT’ scan uses X-rays and a computer to create a series of detailed pictures of your kidneys. This may also require an injection of dye. CT scans have virtually replaced pyelogram and ultrasound as a tool for diagnosing kidney cancer. Magnetic resonance imaging (MRI) uses strong magnets and radio waves to create detailed images of soft tissues in your body. Renal arteriogram is the test used to evaluate the blood supply to the tumor. It is not given often, but may help diagnose small tumors. It has other uses, as well.
These are the stages of kidney cancer. The higher the stage, the more advanced the cancer.
A tumor 7 centimeters or smaller that is only in the kidney
A tumor larger than 7 centimeters that is only in the kidney
- A tumor that is in the kidney and in at least one nearby lymph node
- A tumor that is in the kidney’s main blood vessel and may also be in nearby lymph node
- A tumor that is in the fatty tissue around the kidney and may also involve nearby lymph nodes
- A tumor that extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota’s fascia
Cancer has spread beyond the fatty layer of tissue around the kidney, and it may also be in nearby lymph nodes
Cancer may have spread to other organs, such as the bowel, pancreas, or lungs
Cancer has spread beyond Gerota’s fascia (including contiguous extension into the ipsilateral adrenal gland)
The Global Kidney Cancer Diagnostics and Therapeutics Market was worth $3.11 billion in 2016 and estimated to be growing at a CAGR of 5.64%, to reach $4.09 billion by 2021. North America accounted for the largest share in the global Kidney Cancer Diagnostics and Therapeutics market followed by Asia-Pacific and Europe. The frequency of this disease was higher in developed countries than in developing nations due to lifestyle factors. However, The Asia-Pacific region is anticipated to increase at the highest CAGR during the forecast period due to factors such as low expense of drug production. Major Players include GlaxoSmithKline, Bayer, Pfizer, Sanofi S.A, Hoffmann La Roche, Novartis, Abbott Laboratories.
Want to know more about the Kidney Cancer Diagnostics and Therapeutics Market – Get the insightful Market Research Report by Market Data Forecast today. Grab a Free Report Sample here. To get all the latest updates regarding the Healthcare Industry, follow our Blog and subscribe to our Newsletter.